The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002
Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017
The BAL in the bacteriologic etiology in the COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005
Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Occurrence and impact of bronchiectasis in patients with COPD Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017
Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation Source: Annual Congress 2004 - Role of infection in COPD Year: 2004
Long-term treatment with low-dose azithromycin reduces cough, sputum production and exacerbations in patients with idiopathic diffuse bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004
Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006
Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004
Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012
Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020
Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
Analysis of microbiological colonization in COPD patients with or without bronchiectasis Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019
Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002
Role of colonization on inflammation in COPD patients with bronchiectasis Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008
Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016